I was looking at the print for the casual dining sector this morning, and the headwinds are frankly terrifying. Across the board, foot traffic is steady, but check sizes are plummeting. People are shedding pounds, looking fantastic, and completely destroying the unit economics of the American restaurant industry. The culprit is the GLP-1 agonist, the class of weight-loss drugs like Wegovy and Ozempic that trick the brain into feeling full. While the medical community is popping champagne over normalized blood sugar levels, anyone who understands how an economy actually functions is staring into the abyss.
This is not a trivial metric. The entire casual dining business model is a delicate, beautiful machine predicated on a very specific biological assumption: that the American consumer possesses absolutely zero impulse control. When you walk into an Olive Garden or a Chili's, the synergies of the entire operation depend on your innate inability to say no to the loaded potato skins. The margins on those high-calorie appetizers are what keep the lights on, the fryers hot, and the dividend yields attractive. By utilizing pharmaceuticals to artificially regulate your appetite, you are not just making a lifestyle choice. You are unilaterally renegotiating a social contract with the hospitality sector.
Last week, I sat down for lunch with a managing partner at a major private equity firm that oversees several mid-tier steakhouse concepts. He looked exhausted. He pushed his own forty-dollar wedge salad around his plate, leaned in, and whispered the scariest thing I have heard in my fifteen years covering the Street: people are skipping the apps. Diners are coming in, ordering a single modestly sized entrée, and leaving. They are looking a hardworking restaurateur in the eye and saying they do not care about the establishment's burn rate, they are only going to eat until they are no longer hungry. It is chilling.
The crisis extends far beyond the kitchen. The most devastating blow to the balance sheet is happening at the bar. It is an open secret in the industry that these medications also curb the desire to consume alcohol. A restaurant does not survive by selling you a piece of grilled chicken; it survives by selling you three twenty-two-dollar vodka sodas while you wait for the chicken. When you sit in a premium leather booth for ninety minutes sipping tap water because your pancreas is suddenly communicating effectively with your hypothalamus, you are essentially squatting on commercial real estate.
We spent tens of millions of dollars engineering a menu board with color psychology designed to bypass the prefrontal cortex, and now a weekly injection is completely neutralizing our intellectual property.
Trent is entirely right to be furious. We are witnessing a massive, unconscionable transfer of wealth from honest, hardworking deep-fryer operators to the Danish pharmaceutical cartel. Novo Nordisk's market capitalization recently surpassed the entire gross domestic product of Denmark, and they achieved this by actively suppressing the fundamental driver of the United States economy: the desire to consume something you know will make you feel terrible twenty minutes later. It is tantamount to economic terrorism.
Think of the downstream supply chain. Think of the agricultural sector. There are dairy conglomerates in Wisconsin that expanded their industrial cheese cave footprints based on three-year projections of infinite, boundless gluttony. There are potato farmers in Idaho who bred specific, starch-heavy tubers optimized exclusively for the deep fryer. You are bankrupting heartland farmers just so you can comfortably fit into your college jeans. The sheer selfishness of it takes my breath away.
I saw this entitlement firsthand at a recent networking dinner in Tribeca. A software founder I have known for years, a guy who previously reliably ordered the three-tier seafood tower and a bone-in ribeye for the table, suddenly opted for a small scallop crudo and stopped eating halfway through. When I asked if everything was alright, he smugly mentioned his new GLP-1 regimen and how much mental clarity he had gained. I felt physically sick. Not from overeating, but from the glaring lack of fiduciary duty. He was hoarding capital in his own bank account that rightfully belonged in the restaurant's point-of-sale system.
The National Restaurant Association is reportedly in a state of outright panic, and frankly, they should be aggressively lobbying the federal government. There is a very real antitrust argument to be made here. If a foreign-manufactured peptide sequence physically prevents an American consumer from purchasing a blooming onion, that drug is inherently acting as a restraint of trade. The Justice Department has broken up monopolies for far less.
If this trend of basic biological moderation continues, we will have no choice but to pivot to a subscription-based forced-feeding model just to maintain our current runway.
Some soft-hearted equity analysts argue that restaurants simply need to pivot. They suggest offering smaller portions, healthier options, or adjusting prices to reflect the new reality of the satiated diner. This is exactly the kind of loser mentality that creates down rounds and triggers activist investor proxy fights. You do not right-size the portion. You right-size the consumer. The entire architecture of the S&P 500 relies on limitless growth. You cannot have limitless growth if the consumer's stomach suddenly enforces a hard, unyielding biological boundary.
Let me be clear. I am not unsympathetic to people who want to improve their cardiovascular health or increase their lifespan. But there are ways to accomplish those goals that do not involve actively sabotaging the macroeconomic climate. Go for a run. Buy a Peloton. Sign up for a boutique fitness class you will never attend. Those activities actually create shareholder value. They participate in the ecosystem. Chemically turning off your desire to order a sixteen-dollar brownie sundae at the end of a meal is a hostile act against the free market.
Harrison's frustration is the frustration of every visionary in the hospitality space right now. They built a frictionless pipeline for caloric delivery, and the consumer is suddenly refusing to play their part. We need to ask ourselves what kind of country we want to live in. Do we want a bleak, dystopian landscape where people only consume exactly the amount of fuel their bodies biologically require to function? Or do we want a vibrant, dynamic economy where we order the loaded nachos because it is our patriotic duty?
As for me, I know exactly where I stand. I will be dining out tonight, and I will be ordering the mozzarella sticks, the ribeye, and the cheesecake. I might not finish them. I might feel a profound sense of physical regret by midnight. But as I hand over my corporate card, I will look the waiter in the eye and know with absolute certainty that I did my part to keep the headwinds at bay.